News | April 28, 2026
AstraZeneca wins US nod for at-home lupus treatment in major shift for SLE care
The approval was driven by data from the Phase III TULIP-SC trial
The approval was driven by data from the Phase III TULIP-SC trial
The move brings one of the country’s most widely prescribed blood thinners onto Cost Plus Drug Company’s online pharmacy platform
FTIR and machine learning-based technology enables real-time, cost-effective quantification of food adulterants
Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Collaboration integrates SmartChip PCR technology with cloud-based analytics to enable faster, standardised monitoring of antimicrobial resistance
New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
Minimally invasive laser-based procedure restores blood flow in complex arterial blockage, enables next-day discharge and improved mobility
Subscribe To Our Newsletter & Stay Updated
